French beauty giant L’Oréal is set to acquire British cosmetics brand Medik8 for EUR 1 billion, the Financial Times reported on Wednesday, June 4.
With its focus on anti-aging skincare, Medik8 would be a strategic fit within L’Oréal’s dermatological beauty division, which includes well-known brands like La Roche-Posay and Vichy, and grew by 3.5% in the first-quarter 2025, reaching 2.1 billion euros.
In 2023, L’Oréal acquired the Australian luxury cosmetics brand Aesop, then valued at USD 2.5 billion. The following year, the French group — owner of brands such as Garnier, Maybelline, and L’Oréal Paris —strengthened its presence in the high-end segment through a partnership with Italian luxury group Prada around the Miu Miu brand, and by increasing its stake in the Swiss laboratory Galderma.
Medik8’s main shareholder since 2021 has been the investment fund Inflexion, which supported the British brand in the launch of a new research centre and its expansion in the United States, according to its website.
Founded in 2009 by British Elliot Isaacs, Medik8 has over 300 employees and boasts a range of products manufactured in the UK.
